Hadasit Bio-Holdings Ltd., of Jerusalem, said it received a signed letter of intent for an investment of $2 million from a group of Chinese investors. Read More
HONG KONG – Chinese researchers have discovered a novel nonasaccharide molecule – a nine-unit sugar chain – with potent anticoagulant activity that could avoid adverse effects, paving the way for the development of better treatments for thromboembolic diseases, they reported in the June 22, 2015, early online issue of Proceedings of the National Academy of Sciences. Read More
SHANGHAI – Hangzhou-based Ascletis Inc. is aiming for a home turf advantage with its interferon-free regimen for chronic hepatitis C, having submitted investigational new drug applications to both the Mainland Chinese and Taiwanese Food and Drug Administrations. Read More
NEW DELHI – India has launched a pharmaceutical price databank to be managed and operated by its drug pricing regulator, the National Pharmaceutical Pricing Authority (NPPA), to help consumers make informed product formulation and rate choices. Read More
HONG KONG – An extract of a mushroom used in traditional Chinese medicine (TCM) reduces obesity in mice by altering the composition of the gut microbiota, suggesting it may prove useful for treating obesity and associated disorders in humans, according to a Taiwan study reported in the June 23, 2015, edition of Nature Communications. Read More
